Innovamedica is also co-developing with Tyco Healthcare, a unit of conglomerate Tyco International, a device called a gastric mucosa impedance spectrometer, used to monitor patients in the intensive care unit for signs of organ failure after surgery.
Innovamedica is also co-developing with Tyco Healthcare, a unit of conglomerate Tyco International (nyse: TYC - news - people ), a device called a gastric mucosa impedance spectrometer, used to monitor patients in the intensive care unit for signs of organ failure after surgery.
All ended up seriously ill, with multiple organ failure, soon after being injected with the drug at a special testing unit at Northwick Park Hospital in London, run by a company called Parexel.